Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial

OBJECTIVE: To evaluate if COmbinatie therapie Bij Reumatoïde Artritis (COBRA)-light therapy is cost-effective in treating patients with early rheumatoid arthritis (RA) compared with COBRA therapy. METHODS: This economic evaluation was performed next to the open-label, randomised non-inferiority COBR...

Descripción completa

Detalles Bibliográficos
Autores principales: ter Wee, Marieke M, Coupé, Veerle MH, den Uyl, Debby, Blomjous, Birgit S, Kooijmans, Esmee, Kerstens, Pit JSM, Nurmohamed, Mike T, van Schaardenburg, Dirkjan, Voskuyl, Alexandre E, Boers, Maarten, Lems, Willem F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663254/
https://www.ncbi.nlm.nih.gov/pubmed/29119006
http://dx.doi.org/10.1136/rmdopen-2017-000502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663254/
https://www.ncbi.nlm.nih.gov/pubmed/29119006
http://dx.doi.org/10.1136/rmdopen-2017-000502

Ejemplares similares